National early access programs and clinical trials: What opportunities for early access to therapeutic innovations for patients with malignant melanoma?

Emmanuelle Kempf (1) , Gérard Zalcman (2) , Céleste Lebbe (3)

1 Service d'Oncologie médicale [CHU Henri Mondor]
2 CIC 1425 - Centre d'investigation Clinique [CHU Bichat] - Épidémiologie clinique
3 HIPI (UMR_S_976 / U976) - Immunologie humaine, physiopathologie & immunothérapie

Domaines: Médecine humaine et pathologie

Emmanuelle Kempf, Gérard Zalcman, Céleste Lebbe. National early access programs and clinical trials: What opportunities for early access to therapeutic innovations for patients with malignant melanoma?. Cancer, 2021, 127 (13), pp.2181-2183. ⟨10.1002/cncr.33495⟩. ⟨hal-03560245⟩